CARTESIAN THERAPEUTICS INC
US UEI PXGLS86SY6B1 · SME
8public awards
$12.5Mtotal public funding
2026-04-29latest award
State aid awards (8)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-04-29 | $119k | Grant | TRANS-NIH RESEARCH SUPPORT | Department of Health and Human Services |
| 2025-12-10 | $3.0M | Grant | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DIS | Department of Health and Human Services |
| 2024-08-14 | $149k | Grant | Targeting BCMA+ Cells with RNA-engineered CAR T cells to treat Lupus: | Department of Health and Human Services |
| 2024-06-07 | $3.0M | Grant | Manufacturing RNA-based CAR T cells to combat autoantibody-associated | Department of Health and Human Services |
| 2021-05-01 | $2.0M | Grant | Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distres | Department of Health and Human Services |
| 2020-05-01 | $2.0M | Grant | Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapse | Department of Health and Human Services |
| 2020-04-15 | $2.0M | Grant | Autologous T-cells Expressing a Chimeric Antigen Receptor Directed to | Department of Health and Human Services |
| 2018-08-01 | $299k | Grant | Transient anti-BCMA CAR T-cells for Treatment of Multiple Myeloma | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →